Growth and Adiposity in Newborns: The Influence of Prenatal Docosahexaenoic Acid (DHA) Supplementation (ADORE-GAINS)

University of Kansas logo

University of Kansas

Status

Active, not recruiting

Conditions

Pregnancy; Nutritional Diseases

Treatments

Dietary Supplement: Docosahexaenoic acid

Study type

Observational

Funder types

Other

Identifiers

NCT03310983
STUDY00140895

Details and patient eligibility

About

The purpose of this study is to learn if participants in the ADORE study (NCT02626299), who took a DHA supplement during pregnancy, see favorable body fat in their infants from birth to 24 months, and if excessive or appropriate weight gain during pregnancy impacts this result.

Enrollment

254 patients

Sex

Female

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Participants for this study are invited from the parent study, ADORE. Eligibility listed reflects criteria for the ADORE study.

Inclusion Criteria:

  • Agree to consume study capsules and a typical prenatal supplement of 200 mg DHA
  • Available by telephone

Exclusion Criteria:

  • Expecting multiple infants
  • Gestational age at baseline <12 weeks or >20 weeks
  • Unable or unwilling to agree to consume capsules until delivery
  • Unwilling to discontinue use of another prenatal supplement with DHA that contains ≥ 200 mg DHA
  • Women with allergy to any component of DHA product (including algae), soybean oil or corn oil

Trial design

254 participants in 1 patient group

ADORE Participants
Description:
Participants enrolled in the ADORE study are invited to participate in this study.
Treatment:
Dietary Supplement: Docosahexaenoic acid

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems